WO2009083263A3 - Transport, distribution and/or effective system in aseptic administration - Google Patents

Transport, distribution and/or effective system in aseptic administration Download PDF

Info

Publication number
WO2009083263A3
WO2009083263A3 PCT/EP2008/011155 EP2008011155W WO2009083263A3 WO 2009083263 A3 WO2009083263 A3 WO 2009083263A3 EP 2008011155 W EP2008011155 W EP 2008011155W WO 2009083263 A3 WO2009083263 A3 WO 2009083263A3
Authority
WO
WIPO (PCT)
Prior art keywords
transport
distribution
effective system
collagen
configuring
Prior art date
Application number
PCT/EP2008/011155
Other languages
German (de)
French (fr)
Other versions
WO2009083263A2 (en
Inventor
Arne Briest
Original Assignee
Ossacur Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ossacur Ag filed Critical Ossacur Ag
Publication of WO2009083263A2 publication Critical patent/WO2009083263A2/en
Publication of WO2009083263A3 publication Critical patent/WO2009083263A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0033—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0085—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/009—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures

Abstract

The invention relates to an at least partially bioresorbable transport, distribution and/or effective system having a layer or sandwich structure, comprising a nonwoven material as a frame, into which collagen is built for configuring the layer and/or onto which collagen is bonded for configuring the sandwich structure. At least one of the surfaces of the transport, distribution and/or effective system comprises a substantially porous surface. Additionally, a pharmaceutical can be present. Furthermore, the system may comprise at least one osteoinductive or chondroinductive active substance, such as one of the differentiation and/or growth factors of the TGF ß-super family. The nonwoven material comprises fibers that are selected from cellulose fibers, such as rayon, polyester, polyacryl nitrile, optionally in combination with a super absorber. The invention further relates to a method for the production of the system and to the system as aseptic administration. To this end, the system is located in a container that is closed off by means of a plastic film molded part in the shape of a membrane-like film as a sterile barrier.
PCT/EP2008/011155 2007-12-31 2008-12-31 Transport, distribution and/or effective system in aseptic administration WO2009083263A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007063395.7 2007-12-31
DE200710063395 DE102007063395A1 (en) 2007-12-31 2007-12-31 Transport, transfer and / or action system in aseptic administration

Publications (2)

Publication Number Publication Date
WO2009083263A2 WO2009083263A2 (en) 2009-07-09
WO2009083263A3 true WO2009083263A3 (en) 2010-05-27

Family

ID=40640228

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/011155 WO2009083263A2 (en) 2007-12-31 2008-12-31 Transport, distribution and/or effective system in aseptic administration

Country Status (2)

Country Link
DE (1) DE102007063395A1 (en)
WO (1) WO2009083263A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102022119473A1 (en) 2022-08-03 2024-02-08 Universität Rostock, Körperschaft des öffentlichen Rechts Nonwoven fabric and process for producing a nonwoven fabric

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040126405A1 (en) * 2002-12-30 2004-07-01 Scimed Life Systems, Inc. Engineered scaffolds for promoting growth of cells
WO2006044904A2 (en) * 2004-10-15 2006-04-27 Vanderbilt University Nano- and micro-scale engineering of polymeric scaffolds for vascular tissue engineering
WO2006106506A2 (en) * 2005-04-04 2006-10-12 Technion Research & Development Foundation Ltd. Medical scaffold, methods of fabrication and using thereof
DE102006026592A1 (en) * 2005-12-01 2007-06-06 Ossacur Ag Carrier with Colloss
CA2593380A1 (en) * 2006-06-29 2007-12-29 Depuy Mitek, Inc. Nonwoven tissue scaffold

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA818919B (en) * 1981-04-13 1982-11-24 Seton Co Cosmetic and pharmaceutical sheet material containing polypeptides
DE3429038A1 (en) * 1984-08-07 1986-02-20 B. Braun Melsungen Ag, 3508 Melsungen ACTIVE SUBSTANCE DEPOT
US4950483A (en) 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US5222987A (en) 1989-04-12 1993-06-29 Imperial Chemical Industries Plc Composite material for use in a prosthetic device
DE4404018A1 (en) * 1994-02-09 1995-08-10 Merck Patent Gmbh Protected release dosage forms containing clindamycin palmitate
DE19503336C2 (en) * 1995-02-02 1998-07-30 Lohmann Therapie Syst Lts Pharmaceutical form for delivering active substances to wounds, process for their preparation and their use
TW501934B (en) * 1996-11-20 2002-09-11 Tapic Int Co Ltd Collagen material and process for making the same
US8679525B2 (en) * 2005-10-12 2014-03-25 David M. Dixon Wound care dressing and method using same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040126405A1 (en) * 2002-12-30 2004-07-01 Scimed Life Systems, Inc. Engineered scaffolds for promoting growth of cells
WO2006044904A2 (en) * 2004-10-15 2006-04-27 Vanderbilt University Nano- and micro-scale engineering of polymeric scaffolds for vascular tissue engineering
WO2006106506A2 (en) * 2005-04-04 2006-10-12 Technion Research & Development Foundation Ltd. Medical scaffold, methods of fabrication and using thereof
DE102006026592A1 (en) * 2005-12-01 2007-06-06 Ossacur Ag Carrier with Colloss
CA2593380A1 (en) * 2006-06-29 2007-12-29 Depuy Mitek, Inc. Nonwoven tissue scaffold

Also Published As

Publication number Publication date
WO2009083263A2 (en) 2009-07-09
DE102007063395A1 (en) 2009-07-02

Similar Documents

Publication Publication Date Title
Dias et al. Advances in electrospun skin substitutes
Chaudhari et al. Future prospects for scaffolding methods and biomaterials in skin tissue engineering: a review
Nguyen et al. A combination of biphasic calcium phosphate scaffold with hyaluronic acid-gelatin hydrogel as a new tool for bone regeneration
KR101726885B1 (en) Resorbable scaffolds for bone repair and long bone tissue engineering
Sell et al. Incorporating platelet-rich plasma into electrospun scaffolds for tissue engineering applications
Zhong et al. Tissue scaffolds for skin wound healing and dermal reconstruction
US20150283287A1 (en) Methods and compositions for wound healing
KR101970846B1 (en) Device for ear drum repair
WO2010015419A3 (en) Continuous fiber layer comprising an active substance on the basis of bio-polymers, the use thereof, and method for the production thereof
WO2007134134A3 (en) Reinforced biological tissue
WO2007127795A3 (en) Chitosan/nanocrystalline hydroxyapatite composite microsphere-based scaffolds
Wang et al. Artificial periosteum in bone defect repair—A review
ATE546170T1 (en) WOUND SUTURE WITH BIOLOGICAL MATERIAL
WO2011100425A2 (en) Methods and compositions for wound healing
WO2008027904A3 (en) Dry wound dressing and drug delivery system
WO2008057845A3 (en) Bioabsorbable implantable material fortified with antibiotics for localized delivery of drugs
WO2009147641A3 (en) A device and a system for delivery of biological material
US20150018791A1 (en) Gap-patterned foam dressing and method of making same
JP2009502405A5 (en)
CA2680432A1 (en) Tracheal or tracheostomy tube configuration
AU2016344024A1 (en) Matrix for enhanced delivery of osteoinductive molecules in bone repair
EP2604754A3 (en) Trackbed liner
Busch et al. Functionalization of synthetic bone substitutes
CN104815355A (en) Hydroxyapatite/polyamide composite biological material with nanofiber cellular structure on surface and preparing method thereof
WO2009083263A3 (en) Transport, distribution and/or effective system in aseptic administration

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08866132

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 08866132

Country of ref document: EP

Kind code of ref document: A2